Topical calcineurin inhibitors used to treat atopic dermatitis were not associated with increased risk for either basal cell or squamous cell carcinomas.
Departments, Centers, & Programs:
50 Staniford Street
Boston, MA 02114-2517
- MD, Yale University School of Medicine
- Residency, University of Washington School of Medicine
- Fellowship, UT Southwestern Medical Center
American Board Certifications
- Dermatology, American Board of Dermatology
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.